Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.64 EUR | +0.63% | -4.19% | +10.34% |
Mar. 27 | Nextedia S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Nextedia S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- With a P/E ratio at 10.67 for the current year and 8 for next year, earnings multiples are highly attractive compared with competitors.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.35 for the 2024 fiscal year.
- The company has a low valuation given the cash flows generated by its activity.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company does not generate enough profits, which is an alarming weak point.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Ratings chart - Surperformance
Sector: IT Services & Consulting
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+10.34% | 26.65M | - | ||
-12.23% | 194B | A- | ||
+0.74% | 166B | B+ | ||
+2.19% | 153B | B- | ||
+4.34% | 99.85B | A- | ||
+7.04% | 77.56B | A- | ||
+19.09% | 73.55B | C- | ||
-7.30% | 71B | A | ||
-20.54% | 52.81B | C | ||
+0.53% | 47.86B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- ALNXT Stock
- Ratings NEXTEDIA